DE602006011602D1 - Verfahren zur Diagnose einer Erkrankung mit Beteiligung eines Anti-AT1-Rezeptor-Antikörpers - Google Patents
Verfahren zur Diagnose einer Erkrankung mit Beteiligung eines Anti-AT1-Rezeptor-AntikörpersInfo
- Publication number
- DE602006011602D1 DE602006011602D1 DE602006011602T DE602006011602T DE602006011602D1 DE 602006011602 D1 DE602006011602 D1 DE 602006011602D1 DE 602006011602 T DE602006011602 T DE 602006011602T DE 602006011602 T DE602006011602 T DE 602006011602T DE 602006011602 D1 DE602006011602 D1 DE 602006011602D1
- Authority
- DE
- Germany
- Prior art keywords
- receptor antibody
- diagnosing
- receptor
- disease involving
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06016296A EP1884775B1 (de) | 2006-08-04 | 2006-08-04 | Verfahren zur Diagnose einer Erkrankung mit Beteiligung eines Anti-AT1-Rezeptor-Antikörpers |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006011602D1 true DE602006011602D1 (de) | 2010-02-25 |
Family
ID=37401029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006011602T Active DE602006011602D1 (de) | 2006-08-04 | 2006-08-04 | Verfahren zur Diagnose einer Erkrankung mit Beteiligung eines Anti-AT1-Rezeptor-Antikörpers |
Country Status (7)
Country | Link |
---|---|
US (1) | US8425877B2 (de) |
EP (2) | EP1884775B1 (de) |
AT (2) | ATE454630T1 (de) |
DE (1) | DE602006011602D1 (de) |
ES (2) | ES2336350T3 (de) |
PL (2) | PL1884775T3 (de) |
WO (1) | WO2008015218A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10123929A1 (de) | 2001-05-11 | 2002-11-21 | Celltrend Gmbh | Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit |
EP1884776A1 (de) * | 2006-08-04 | 2008-02-06 | Celltrend GmbH | Verfahren zur diagnose einer krankheit, die auf der gegenwart des anti-endothelin-antikörpers beruht |
PL1884775T3 (pl) | 2006-08-04 | 2010-06-30 | Celltrend Gmbh | Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1 |
BR112012026006A2 (pt) * | 2010-04-12 | 2019-09-24 | Cell Trend GmbH | método para diagnose de esclerose múltipla envolvendo anticorpo antirreceptor at1 |
US8483415B2 (en) | 2010-06-18 | 2013-07-09 | Motorola Mobility Llc | Antenna system with parasitic element for hearing aid compliant electromagnetic emission |
US10648977B2 (en) | 2015-10-30 | 2020-05-12 | The Johns Hopkins University | Angiotensin receptor autoantibodies as biomarker for effected usage of angiotensin receptor blockers |
WO2017123550A1 (en) * | 2016-01-11 | 2017-07-20 | Autotelic Llc | Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension |
CN108948183B (zh) * | 2018-06-05 | 2022-01-28 | 武汉华纪元生物技术开发有限公司 | α1受体和AT1受体抗原类似物多肽及其抗体检测试剂盒和应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2866182B2 (ja) | 1990-10-08 | 1999-03-08 | 日本ケミファ株式会社 | エンドセリン受容体 |
FR2787330A1 (fr) | 1998-12-18 | 2000-06-23 | Sanofi Sa | Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe |
JP2002539075A (ja) | 1998-12-24 | 2002-11-19 | マックス−デルブルック−セントラム フュール モレクラーレ メディツィン | At1受容体のペプチド、及び子癇前症、悪性高血圧症におけるその使用 |
DE19954305A1 (de) | 1998-12-24 | 2000-06-29 | Max Delbrueck Centrum | Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie |
CA2314811A1 (en) * | 2000-08-02 | 2002-02-02 | Brian Archibald Macvicar | Autoimmunity to angiotensin at1 receptors in schizophrenia |
DE10123929A1 (de) * | 2001-05-11 | 2002-11-21 | Celltrend Gmbh | Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit |
US20030078190A1 (en) * | 2001-05-25 | 2003-04-24 | Weinberg Marc S. | Methods for tissue protection using highly effective inhibition of the renin-angiotensin system |
EP1570272A2 (de) * | 2002-11-29 | 2005-09-07 | Max-Delbrück-Centrum Für Molekulare Medizin | Bestimmung agonistischer autoantikörper |
US20060135422A1 (en) * | 2003-04-17 | 2006-06-22 | Moskowitz David W | Use of angiotensin receptor blockers (ARBs) to treat diseases associated with excess ACE |
WO2006060336A2 (en) | 2004-11-30 | 2006-06-08 | The Johns Hopkins University | Endothelin-2 and retinal damage |
EP1884776A1 (de) | 2006-08-04 | 2008-02-06 | Celltrend GmbH | Verfahren zur diagnose einer krankheit, die auf der gegenwart des anti-endothelin-antikörpers beruht |
PL1884775T3 (pl) | 2006-08-04 | 2010-06-30 | Celltrend Gmbh | Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1 |
-
2006
- 2006-08-04 PL PL06016296T patent/PL1884775T3/pl unknown
- 2006-08-04 AT AT06016296T patent/ATE454630T1/de not_active IP Right Cessation
- 2006-08-04 ES ES06016296T patent/ES2336350T3/es active Active
- 2006-08-04 EP EP06016296A patent/EP1884775B1/de active Active
- 2006-08-04 DE DE602006011602T patent/DE602006011602D1/de active Active
-
2007
- 2007-07-31 ES ES07802440T patent/ES2369798T3/es active Active
- 2007-07-31 EP EP07802440A patent/EP2057467B1/de active Active
- 2007-07-31 US US12/376,164 patent/US8425877B2/en active Active
- 2007-07-31 WO PCT/EP2007/057910 patent/WO2008015218A2/en active Application Filing
- 2007-07-31 PL PL07802440T patent/PL2057467T3/pl unknown
- 2007-07-31 AT AT07802440T patent/ATE518139T1/de active
Also Published As
Publication number | Publication date |
---|---|
EP1884775A1 (de) | 2008-02-06 |
PL2057467T3 (pl) | 2011-12-30 |
US20100098688A1 (en) | 2010-04-22 |
EP1884775B1 (de) | 2010-01-06 |
WO2008015218A2 (en) | 2008-02-07 |
PL1884775T3 (pl) | 2010-06-30 |
US8425877B2 (en) | 2013-04-23 |
ES2336350T3 (es) | 2010-04-12 |
EP2057467A2 (de) | 2009-05-13 |
ES2369798T3 (es) | 2011-12-07 |
WO2008015218A3 (en) | 2008-07-03 |
EP2057467B1 (de) | 2011-07-27 |
ATE454630T1 (de) | 2010-01-15 |
ATE518139T1 (de) | 2011-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE518139T1 (de) | Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers | |
NZ592358A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2) | |
ATE493649T1 (de) | Verfahren zur diagnose von polyzystischer nierenkrankheit | |
ATE550658T1 (de) | Verfahren für den nachweis oder die diagnose neurodegenerativer erkrankungen oder leiden | |
WO2009001545A1 (ja) | 移植片対宿主疾患の検査および治療方法 | |
EP3264090A3 (de) | Verfahren zur erkennung von nukleosomaddukten | |
AR086734A1 (es) | Metodos de diagnostico de la enfermedad tromboembolica | |
ATE514948T1 (de) | In vitro verfahren zur diagnose von neurodegenerativen erkrankungen | |
DE502006008028D1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
WO2008122670A3 (en) | Human diabetes susceptibility tnfrsf10b gene | |
NZ600160A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
CY1122202T1 (el) | Προσδιορισμος κινδυνου για θεραπεια αντιβιοτικων σε ασθενεις οι οποιοι υποφερουν απο πρωτοπαθη μη μολυσματικη νοσο δια καθορισμου του επιπεδου προκαλσιτονινης | |
DE602007007775D1 (de) | Reagenz für hämoglobinabbau | |
EP1977234A4 (de) | Moleküle zur behandlung von lungenerkrankungen mit einer immunreaktion mit verbindungsgewebe in der lunge | |
DE602006002490D1 (de) | Verfahren zur diagnose von tumoren | |
DE602006020850D1 (de) | Biomarker zur diagnose einer herzerkrankung sowie verwendung davon | |
ATE472611T1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression | |
ATE528651T1 (de) | Diagnoseverfahren für pulmonale arterielle hypertonie | |
CY1111602T1 (el) | ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ | |
FR2946349B1 (fr) | Sequences, anticorps, procedes et necessaires pour la detection et le dosage in vitro de la periostine, en vue du diagnostic du suivi ou du pronostic de pathologies ou de phenomenes biologiques impliquant la periostine | |
RU2009146803A (ru) | Способ диагностики деструктивного панкреатита | |
BR112013030646A2 (pt) | uso diagnóstico de pró-somatostatina | |
ATE509270T1 (de) | Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung | |
ATE528650T1 (de) | Verfahren zum nachweis und zur diagnose einer infektion mit trypanosoma cruzi | |
WO2010093214A3 (en) | Monoclonal antibody recognizing scye1 and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |